HRMY
Harmony Biosciences Holdings, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares -5.6% ·
flujo de acciones -0.8% ·
nuevas posiciones netas -5.9%
· fórmula
Distribución amplia: acciones en descenso y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 111 | +5 | 37.63M | $1.37B | +12 | −8 |
| Q1 2026 | 110 | -3 | 39.20M | $1.10B | +5 | −9 |
| Q4 2025 | 114 | +1 | 39.01M | $1.46B | +2 | n/a |
| Q3 2025 | 20 | +1 | 24.69M | $680.58M | +2 | −2 |
| Q2 2025 | 17 | -1 | 23.07M | $729.13M | +1 | −2 |
| Q1 2025 | 15 | +1 | 6.74M | $223.55M | +1 | n/a |
| Q4 2024 | 14 | -1 | 7.61M | $261.77M | n/a | −1 |
| Q3 2024 | 14 | +1 | 3.56M | $142.57M | +1 | n/a |
| Q2 2024 | 13 | n/a | 3.50M | $105.70M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 6.74M | n/a | $212.89M | 0.0% | n/c | 1 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (pasivo) | 5.11M | n/a | $161.50M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Fidelity (FMR) ✦ | 4.69M | n/a | $148.15M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 4 | State Street Global Advisors ✦ (pasivo) | 1.63M | +3.2% | $51.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Marshall Wace ✦ | 1.21M | +36.3% | $38.22M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (pasivo) | 1.05M | +9.2% | $33.32M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Renaissance Technologies ✦ | 929.47K | +10.6% | $29.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | Arrowstreet Capital ✦ | 906.91K | +127.6% | $28.66M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 252.98K | -20.9% | $7.99M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 10 | Two Sigma Investments ✦ | 238.89K | -30.9% | $7.55M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 152.03K | -8.6% | $4.80M | 0.0% | ▼ Trim | 5 | SEC ↗ ×5 |
| 12 | Gotham Asset Management ✦ | 39.71K | +71.4% | $1.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 34.83K | +16.7% | $1.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 33.78K | Nuevo | $1.07M | 0.0% | New | 1 | SEC ↗ |
| 15 | Millennium Management ✦ | 29.29K | -62.7% | $925,532 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Wellington Management ✦ | 15.73K | -3.8% | $497,131 | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 17 | Norges Bank ✦ (pasivo) | 11.12K | -79.4% | $351,487 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Point72 Asset Management | $1.07M | 0.0% |
Posición cerrada
| Citadel Advisors | $28.62M | era 0.0% |
| Adage Capital Partners | $5.58M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 306 tenedores, 54.70M acciones, $1.38B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 35.85K acc. · $1.54M
Officer · 800 acc. · $34,400
Officer · 1.80K acc. · $77,426
Officer · 22.95K acc. · $989,350
Officer · 1.00K acc. · $42,795
Officer · 4.50K acc. · $190,114
Officer · 5.50K acc. · $230,911
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología